middle.news
SomnoMed Surpasses $111m Revenue, Eyes 25% Capacity Boost in FY26
2:17am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
SomnoMed Surpasses $111m Revenue, Eyes 25% Capacity Boost in FY26
2:17am on Saturday 30th of August, 2025 AEST
Key Points
FY25 revenue up 21.6% to $111.5 million, beating guidance
EBITDA jumps to $9.2 million, surpassing forecast range
Order backlog reduced to negligible levels amid capacity upgrades
FDA clearance for Rest Assure compliance tracking device
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Somnomed (ASX:SOM)
OPEN ARTICLE